Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

blog_import_53218506861ce.jpg
According to a new market report published by Transparency Market Research "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019,"the market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/nanomedicine-market.html

The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.

The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.

However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.

North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.

Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.

Related & Recently Published Reports by Transparency Market Research

Operating Room Equipment Market (Operating Tables, Operating Room Lights, Surgical Booms, Operating Room Integration Systems and Surgical Imaging Displays) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

http://www.transparencymarketresearch.com/operating-room-equipment.html

This report studies the current scenario as well as the future potential for operating room equipment market, globally. The major operating room equipment types studied in this report are operating tables, operating room lights, surgical booms, operating room integration systems and surgical imaging displays. The market for these equipment have been extensively analyzed on the basis of factors such as product types, technological developments, pricing and availability across various geographies. The market size and forecasts in terms of revenue (USD million) for each operating room equipment category have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the % compounded annual growth rate (CAGR) for the global operating room equipment market as well as for each segment, for the forecast period 2013 to 2019.

The global operating room equipment market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in various countries of these regions. The market overview section of the report comprises qualitative analysis of the overall operating room equipment market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with the Porter’s five force analysis and market attractiveness analysis.



The global nanomedicine market is categorized into the following segments:

Nanomedicine Market by Application
Neurology
Cardiovascular
Anti-Inflammatory
Anti-Infectives
Oncology
Others
Nanomedicine Market by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)


Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
blog_import_5321850579042.jpg


Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Global Nanomedicine Market Overview

3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Improvement in technology for nanomedicine
3.1.1.2 Rising government support for research and development in nanomedicine
3.1.1.3 Presence of high unmet medical needs
3.1.1.4 Increase in investment amount and healthcare collaborations
3.1.1.5 High prevalence of chronic diseases
3.1.1.6 Impact Analysis of the Market Drivers
3.1.2 Market Restraints
3.1.2.1 Lack of organized regulatory framework
3.1.2.2 High costs involved
3.1.2.3 Impact Analysis of the Market Restraints
3.1.3 Market Opportunities
3.1.3.1 Presence of unmet medical needs in emerging economies
3.1.3.2 Identification of new medical applications
3.2 Porter’s Five Forces Analysis: Global Nanomedicine Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
3.4 Global Nanomedicine Market, 2011 – 2019 (USD Million)

Chapter 4 Global Nanomedicine Market, by Applications
4.1 Overview
4.2 Nanomedicine for Neurology
4.2.1 Global Nanomedicine for Neurology Market, 2011 – 2019 (USD Billion)
4.3 Nanomedicine for Cardiovascular (CVS)
4.3.1 Global Nanomedicine for Cardiovascular Market , 2011 – 2019 (USD Billion)
4.4 Nanomedicine for Oncology
4.4.1 Global Nanomedicine for Oncology Market , 2011 – 2019 (USD Billion)
4.5 Nanomedicine for Anti-inflammatory
4.5.1 Global Nanomedicine for Anti-Inflammatory Market, 2011 – 2019 (USD Billion)
4.6 Nanomedicine for Anti-infectives
4.6.1 Global Nanomedicine for Anti-Infectives Market, 2011 – 2019 (USD Billion)
4.7 Other Applications
4.7.1 Global Nanomedicine Market for Other Applications, 2011 – 2019 (USD Billion)
4.8 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (%)

Chapter 5 Global Nanomedicine Market, by Geography
5.1 Overview
5.1.1 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 & 2019 (%)
5.2 North America
5.2.1 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
5.5 Rest of the World
5.5.1 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)

Chapter 6 Recommendations
6.1 Collaborating with educational institutions to boost interdisciplinary education and training
6.2 Identifying and prioritizing key growth areas

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 CombiMatrix Corporation
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Celgene Corporation
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Mallinckrodt plc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 GE Healthcare
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Merck & Company Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Nanosphere, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Pfizer Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.10 Sigma-Tau Pharmaceuticals Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategy
7.11.5 Recent Developments
7.12 UCB SA
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Product Portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments

Topic : Global Information
Genre : News

Post a comment

Private comment

Profile

marketsize

Author:marketsize
I am Research Analyst And Business Development Manager At Transparency Market Research

Visit http://www.transparencymarketresearch.com/

Latest journals
Monthly archive
Category
Search form
Link
Friend request form

Want to be friends with this user.

QR code
QR